Clinical Trial Update: Evaluation of Ubiquinol on Mitochondrial Oxidative Capacity in Statin Patients Using 31PMRS [NA]

View source ↗

Summary

A completed clinical trial evaluated the effect of ubiquinol on mitochondrial oxidative capacity in statin users and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia
• Statin-associated Myopathy

Drugs mentioned

• Ubiquinol (ubiquinol)

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Myopathy, HMG COA Reductase Inhibitor Adverse Reaction | NA | Status: COMPLETED | Results posted: 2017-04-17